We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
-2.85%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$338M
AUM Growth
+$25.6M
Cap. Flow
+$47.9M
Cap. Flow %
14.16%
Top 10 Hldgs %
83.48%
Holding
57
New
29
Increased
2
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
EXAI
Exscientia Plc American Depositary Shares
EXAI
+$16.2M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$7.59M
3
PACB icon
Pacific Biosciences
PACB
+$4.15M
4
ONC
BeOne Medicines Ltd
ONC
+$3.78M
5
INCY icon
Incyte
INCY
+$2.33M

Top Sells

Rank Stock Value
1
FLNT
Fluent
FLNT
+$442K
2
AKRO
Akero Therapeutics
AKRO
+$78K

Sector Composition

Rank Sector Weight
1 Healthcare 69.71%
2 Financials 28.31%
3 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NFH
1
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$95.7M 28.31%
8,350,000
– –
ILMN icon
2
Illumina
ILMN
$31B
$49.3M 14.59%
133,277
– –
HRMY icon
3
Harmony Biosciences
HRMY
$2.08B
$32.8M 9.7%
768,708
– –
KRTX
4
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$30.8M 9.1%
234,811
– –
SLGC
5
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$19.7M 5.84%
1,696,558
– –
EXAI
6
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$15.2M 4.5%
+770,200
New +$16.2M
EAR
7
DELISTED
Eargo, Inc. Common Stock
EAR
$14.7M 4.36%
144,336
– –
VIR icon
8
Vir Biotechnology
VIR
$1.5B
$8.82M 2.61%
210,563
+50,352
+31% +$1.97M
RANI icon
9
Rani Therapeutics
RANI
$92.2M
$8.07M 2.39%
493,584
– –
SGEN
10
DELISTED
Seagen Inc. Common Stock
SGEN
$7.01M 2.07%
+45,340
New +$7.59M
XENE icon
11
Xenon Pharmaceuticals
XENE
$6.2B
$6.18M 1.83%
197,880
– –
BOLT icon
12
Bolt Biotherapeutics
BOLT
$7.47M
$5.72M 1.69%
58,348
– –
BEAM icon
13
Beam Therapeutics
BEAM
$2.73B
$4.38M 1.29%
54,903
– –
NFH.WS
14
DELISTED
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
$4.27M 1.26%
1,580,000
– –
PACB icon
15
Pacific Biosciences
PACB
$460M
$3.51M 1.04%
+171,760
New +$4.15M
ONC
16
BeOne Medicines Ltd
ONC
$33.4B
$3.04M 0.9%
+11,205
New +$3.78M
GRTX
17
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$2.81M 0.83%
613,223
– –
INCY icon
18
Incyte
INCY
$24.9B
$2.53M 0.75%
+34,510
New +$2.33M
NVTA
19
DELISTED
Invitae Corporation
NVTA
$2.41M 0.71%
157,862
+13,195
+9% +$285K
OTIC
20
DELISTED
Otonomy, Inc.
OTIC
$1.77M 0.52%
851,000
– –
ASND icon
21
Ascendis Pharma A/S
ASND
$16.5B
$1.7M 0.5%
+12,600
New +$1.87M
TVTX icon
22
Travere Therapeutics
TVTX
$5.33B
$1.5M 0.45%
+48,500
New +$1.37M
EXAS
23
DELISTED
Exact Sciences
EXAS
$1.36M 0.4%
17,464
– –
EXEL icon
24
Exelixis
EXEL
$14.1B
$1.17M 0.35%
64,200
– –
SRRA
25
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.15M 0.34%
52,979
– –
1
2 3

Similar funds

TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Nan Fung Group Holdings's Q4 2021 Portfolio in Review

As of Q4 2021, Nan Fung Group Holdings held 57 positions worth $338M, up 8.2% from $312M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Nan Fung Group Holdings deployed $47.9M of net new capital in Q4 2021, opening 29 new positions and adding to 2 existing holdings. Its largest new stake was Exscientia Plc American Depositary Shares: 770,200 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 67% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the most notable exit was Fluent, an estimated $442K sold.

  • Nan Fung Group Holdings's largest Q4 2021 buy was Exscientia Plc American Depositary Shares: 770,200 shares worth $15.2M.
  • Nan Fung Group Holdings added most to Vir Biotechnology in Q4 2021, an estimated $1.97M increase.
  • Nan Fung Group Holdings fully exited Fluent in Q4 2021, selling an estimated $442K.
  • Nan Fung Group Holdings's ten largest holdings make up 83% of its $338M portfolio in Q4 2021.
  • Nan Fung Group Holdings opened 29 new positions and closed 2 in Q4 2021.
  • Nan Fung Group Holdings's portfolio value rose 8.2% quarter-over-quarter to $338M.

Based on Nan Fung Group Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.